Amkay Products Share Price Today | Stock Price & Amkay Products Share Screener
Track the current Amkay Products share price and stock price live with TickJournal's free stock screener. Check AMKAY 52-week chart for the annual price range and momentum. Use the Amkay Products stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amkay Products opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹18 and net income of ₹1, with EBITDA of ₹2, an operating margin of 5.0% and a profit margin of 5.6%.
Amkay Products Share Price Chart
Track the current stock price of Amkay Products with an interactive chart. Analyse AMKAY share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amkay Products stock quote in one place.
Amkay Products Company Profile - Fundamental Screener
Screen Amkay Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMKAY shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE0QSB01016.
Company Details
Classification
Identifiers and Leadership
Amkay Products Balance Sheet Screener
Screen AMKAY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹30, up from ₹18 in 2024.
Latest statistics put total assets at ₹30 and shareholder funds at ₹24, with a leverage ratio of 0.24.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 30 | 18 | 15 | 16 | 14 |
| Current Assets | 17 | 12 | 9 | 10 | 10 |
| Fixed Assets | 4 | 3 | 2 | 4 | 2 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 3 | 4 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 24 | 10 | 7 | 6 | 5 |
| Share Capital | 9 | 6 | 0 | 0 | 0 |
| Reserves & Surplus | 15 | 4 | 7 | 6 | 5 |
Amkay Products Income Statement Screener - Profit & Revenue Analysis
Screen Amkay Products income statement and profit fundamentals. Analyze AMKAY quarterly results. Amkay Products reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹18 and net profit was ₹1, equal to earnings per unit of ₹2.10, at an operating margin of 5%.
In that period expenses were ₹15, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹40 and net profit of ₹3.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||
| Revenue | 18 | 40 | 32 | 28 | 37 | 41 |
| Expenses | 15 | 34 | 28 | 25 | 34 | 36 |
Operating Costs and Margins | ||||||
| EBITDA | 2 | 5 | 5 | 3 | 3 | 5 |
| Operating Profit % | 5.00% | 11.00% | 11.00% | 11.00% | 7.00% | 11.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 0 |
| Interest | 0 | 0 | 1 | 1 | 0 | 0 |
Profit and Earnings | ||||||
| Profit Before Tax | 2 | 4 | 4 | 2 | 2 | 4 |
| Tax | 0 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 1 | 3 | 3 | 2 | 2 | 3 |
| EPS | 2.10 | 3.96 | 4.13 | 2.43 | 2.31 | 4.91 |
Amkay Products Cash Flow Screener - Liquidity Fundamentals
Screen AMKAY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹0, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹6 and financing activities provided ₹8.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | 0 | -1 | 0 | 0 | 0 | 0 |
| Investing Activities | -6 | 1 | 0 | -3 | 0 | 0 |
Financing and Net Cash | ||||||
| Financing Activities | 8 | 0 | 0 | 3 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | -1 | 0 | 0 |
Amkay Products Shareholding Pattern Screener
See Amkay Products shareholding pattern with promoter, FII, and DII holdings. Check Amkay Products promoter holding and ownership changes for AMKAY on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 73.44%, foreign institutions 0.00%, domestic institutions 0.00% and the public 23.23%, spread across 584 shareholders.
The shareholder count was 584 in 2025-Mar, compared with 548 in 2025-Jun.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar | 2024-Apr | 2024-May |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 73.44% | 73.44% | 73.44% | 73.44% | 99.89% | 73.44% | 99.89% | 99.89% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.25% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.47% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.23% | 23.44% | 23.21% | 23.33% | 0.00% | 11.59% | 0.00% | 0.00% |
| Other Holding | 3.33% | 3.12% | 3.35% | 3.23% | 0.11% | 3.26% | 0.11% | 0.11% |
| Shareholder Count | 584 | 548 | 506 | 415 | 8 | 621 | 8 | 8 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amkay Products. Amkay Products dividend yield can be compared with peers and other stocks in the market.
Amkay Products Stock Index Membership - Nifty & Sensex
See which indices include Amkay Products stock. Check AMKAY index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Amkay Products Market Events Screener - Corporate Actions
Get Amkay Products corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amkay Products stock events that may affect AMKAY share price, along with derivatives, futures and options activity and sector gainers.
6 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Annual General Meeting dated and Quarterly Result Announcement dated November 12, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -15.88% | ||
| Annual General Meeting | NA | -10.42% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.09% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -2.17% |
| 2024-11-29 | 2024-11-29 | Quarterly Result Announcement | NA | 5.26% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.06% |
Amkay Products Competitors Screener - Peer Stocks Comparison
Screen AMKAY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 12,578 | 36.04 | 1,759 | 22.62% | 339 | 39.22 |
| Tarsons Products | 982 | 47.68 | 408 | 32.64% | 30 | 39.87 |
| Laxmi Dental | 955 | 42.19 | 242 | 24.12% | 25 | 37.86 |
| Osel Devices | 922 | 45.05 | 187 | 40.62% | 20 | 55.37 |
| Vasa Denticity | 690 | 52.53 | 251 | 45.01% | 17 | 32.34 |
| Fabtech Technologies | 647 | 20.32 | 336 | 45.66% | 47 | 45.32 |
| Prevest Denpro | 457 | 22.79 | 67 | 13.15% | 18 | 29.92 |
| Aprameya Engineering | 415 | 25.44 | 136 | 107.77% | 16 | 45.60 |
| Hemant Surgical Industries | 359 | 43.31 | 112 | % | 8 | 49.87 |
| Nureca | 238 | 21.60 | 122 | 19.24% | 1 | 29.81 |
Amkay Products Company Announcements - News & Reports Screener
Screen AMKAY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated January 7, 2026.
The next most recent announcements are dated December 12, 2025 and December 11, 2025.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-12 | Reply To Clarification On Price Movement Sought By BSE Limited | - |
| 2025-12-11 | Clarification sought from Amkay Products Ltd | - |
| 2025-11-12 | Unaudited Financial Result For The Half Year Ended September 30 2025 | - |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 12Th November 2025 For Consider And Approve The Unaudited Financial Result For The Half Year Ended September 30 2025 | - |
| 2025-11-06 | Board Meeting Intimation for Consider And Approve The Unaudited Financial Result For The Half Year Ended September 30 2025 | - |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-27 | Closure of Trading Window | - |
| 2025-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-09-06 | Intimation Of Book Closure For The Purpose Of Annual General Meeting | - |
| 2025-09-06 | Reg. 34 (1) Annual Report. | - |
| 2025-09-06 | Notice Of 18Th Annual General Meeting To Be Held On Monday 29Th September 2025 Through Vc/Oavm. | - |
| 2025-07-02 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-05-23 | Audited Financial Result For The Financial Year 31St March 2025 | - |
| 2025-05-23 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May 2025 | - |
| 2025-05-14 | Board Meeting Intimation for Board Meeting Intimation For Considering And Adopting The Audited Financial Results For The Quarter And Financial Year Ended 31St March 2025 | - |
| 2025-04-22 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2025-04-22 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 14.68 and the P/B ratio is 2.04, with earnings per unit of ₹3.96. Market capitalisation stands at ₹49.38 Cr. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.